Terms: = Thyroid cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Prognosis
13 results:
1. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary thyroid cancer.
Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
[TBL] [Abstract] [Full Text] [Related]
2. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
Sahin I; Saat H
Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
[No Abstract] [Full Text] [Related]
3. Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
Hu W; Li M; Zhang Q; Liu C; Wang X; Li J; Qiu S; Li L
J Ovarian Res; 2021 Aug; 14(1):103. PubMed ID: 34364397
[TBL] [Abstract] [Full Text] [Related]
4. Alternative splicing events implicated in carcinogenesis and prognosis of thyroid gland cancer.
Wu ZH; Tang Y; Zhou Y
Sci Rep; 2021 Mar; 11(1):4841. PubMed ID: 33649373
[TBL] [Abstract] [Full Text] [Related]
5. Highly accurate diagnosis of papillary thyroid carcinomas based on personalized pathways coupled with machine learning.
Park KS; Kim SH; Oh JH; Kim SY
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33341874
[TBL] [Abstract] [Full Text] [Related]
6. Is thyroid cancer prognosis affected by solid organ transplantation?
Webb C; Cronin P; Gupta N; Verhey J; Calderon E; Moss A; Mathur AK; Pockaj B; Wasif N; Stucky CC
Surgery; 2021 Jan; 169(1):58-62. PubMed ID: 32814633
[TBL] [Abstract] [Full Text] [Related]
7. Identification of an immune-related key gene, PPARGC1A, in the development of anaplastic thyroid carcinoma: in-silico study and in-vitro evaluation.
Huang Y; Ling J; Chang A; Ye H; Zhao H; Zhuo X
Minerva Endocrinol (Torino); 2022 Jun; 47(2):150-159. PubMed ID: 32720497
[TBL] [Abstract] [Full Text] [Related]
8. Unstimulated high-sensitive thyroglobulin is a powerful prognostic predictor in patients with thyroid cancer.
Giovanella L; Castellana M; Trimboli P
Clin Chem Lab Med; 2019 Dec; 58(1):130-137. PubMed ID: 31444962
[TBL] [Abstract] [Full Text] [Related]
9. Abnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.
Liang Z; Sun XY; Xu LC; Fu RZ
Med Sci Monit; 2014 Dec; 20():2776-82. PubMed ID: 25553984
[TBL] [Abstract] [Full Text] [Related]
10. E-cadherin expression is more associated with histopathological type of thyroid cancer than with the metastatic potential of tumors.
Slowinska-Klencka D; Sporny S; Stasikowska-Kanicka O; Popowicz B; Klencki M
Folia Histochem Cytobiol; 2012; 50(4):519-26. PubMed ID: 23264214
[TBL] [Abstract] [Full Text] [Related]
11. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract] [Full Text] [Related]
12. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW
J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
[TBL] [Abstract] [Full Text] [Related]
13. [Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma].
Liu Y; Jiang C; Tan Y
Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):322-6. PubMed ID: 12417089
[TBL] [Abstract] [Full Text] [Related]
